These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 29795142)

  • 1. Serum cholesterol levels and tumor growth in a PTEN-null transgenic mouse model of prostate cancer.
    Allott EH; Masko EM; Freedland AR; Macias E; Pelton K; Solomon KR; Mostaghel EA; Thomas GV; Pizzo SV; Freeman MR; Freedland SJ
    Prostate Cancer Prostatic Dis; 2018 Jun; 21(2):196-203. PubMed ID: 29795142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence for Feedback Regulation Following Cholesterol Lowering Therapy in a Prostate Cancer Xenograft Model.
    Masko EM; Alfaqih MA; Solomon KR; Barry WT; Newgard CB; Muehlbauer MJ; Valilis NA; Phillips TE; Poulton SH; Freedland AR; Sun S; Dambal SK; Sanders SE; Macias E; Freeman MR; Dewhirst MW; Pizzo SV; Freedland SJ
    Prostate; 2017 Apr; 77(5):446-457. PubMed ID: 27900797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of carbohydrate restriction in the context of obesity on prostate tumor growth in the Hi-Myc transgenic mouse model.
    Allott EH; Macias E; Sanders S; Knudsen BS; Thomas GV; Hursting SD; Freedland SJ
    Prostate Cancer Prostatic Dis; 2017 Jun; 20(2):165-171. PubMed ID: 28244492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted biallelic inactivation of Pten in the mouse prostate leads to prostate cancer accompanied by increased epithelial cell proliferation but not by reduced apoptosis.
    Ma X; Ziel-van der Made AC; Autar B; van der Korput HA; Vermeij M; van Duijn P; Cleutjens KB; de Krijger R; Krimpenfort P; Berns A; van der Kwast TH; Trapman J
    Cancer Res; 2005 Jul; 65(13):5730-9. PubMed ID: 15994948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Notch promotes tumor metastasis in a prostate-specific Pten-null mouse model.
    Kwon OJ; Zhang L; Wang J; Su Q; Feng Q; Zhang XH; Mani SA; Paulter R; Creighton CJ; Ittmann MM; Xin L
    J Clin Invest; 2016 Jul; 126(7):2626-41. PubMed ID: 27294523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conditional deletion of the Pten gene in the mouse prostate induces prostatic intraepithelial neoplasms at early ages but a slow progression to prostate tumors.
    Kwak MK; Johnson DT; Zhu C; Lee SH; Ye DW; Luong R; Sun Z
    PLoS One; 2013; 8(1):e53476. PubMed ID: 23308230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conditional PTEN-deficient mice as a prostate cancer chemoprevention model.
    Koike H; Nozawa M; De Velasco MA; Kura Y; Ando N; Fukushima E; Yamamoto Y; Hatanaka Y; Yoshikawa K; Nishio K; Uemura H
    Asian Pac J Cancer Prev; 2015; 16(5):1827-31. PubMed ID: 25773832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pomegranate extracts impact the androgen biosynthesis pathways in prostate cancer models in vitro and in vivo.
    Ming DS; Pham S; Deb S; Chin MY; Kharmate G; Adomat H; Beheshti EH; Locke J; Guns ET
    J Steroid Biochem Mol Biol; 2014 Sep; 143():19-28. PubMed ID: 24565566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of Heterogeneous Prostate Tumors in Targeted Pten Knockout Mice.
    Korsten H; Ziel-van der Made AC; van Weerden WM; van der Kwast T; Trapman J; Van Duijn PW
    PLoS One; 2016; 11(1):e0147500. PubMed ID: 26807730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Temporally controlled ablation of PTEN in adult mouse prostate epithelium generates a model of invasive prostatic adenocarcinoma.
    Ratnacaram CK; Teletin M; Jiang M; Meng X; Chambon P; Metzger D
    Proc Natl Acad Sci U S A; 2008 Feb; 105(7):2521-6. PubMed ID: 18268330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The influence of growth hormone/insulin-like growth factor deficiency on prostatic dysplasia in pbARR2-Cre, PTEN knockout mice.
    Takahara K; Ibuki N; Ghaffari M; Tearle H; Ong CJ; Azuma H; Gleave ME; Pollak M; Cox ME
    Prostate Cancer Prostatic Dis; 2013 Sep; 16(3):239-47. PubMed ID: 23689346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Slow disease progression in a C57BL/6 pten-deficient mouse model of prostate cancer.
    Svensson RU; Haverkamp JM; Thedens DR; Cohen MB; Ratliff TL; Henry MD
    Am J Pathol; 2011 Jul; 179(1):502-12. PubMed ID: 21703427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cooperation between Stat3 and Akt signaling leads to prostate tumor development in transgenic mice.
    Blando JM; Carbajal S; Abel E; Beltran L; Conti C; Fischer S; DiGiovanni J
    Neoplasia; 2011 Mar; 13(3):254-65. PubMed ID: 21390188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of MAOA in epithelia inhibits adenocarcinoma development, cell proliferation and cancer stem cells in prostate.
    Liao CP; Lin TP; Li PC; Geary LA; Chen K; Vaikari VP; Wu JB; Lin CH; Gross ME; Shih JC
    Oncogene; 2018 Sep; 37(38):5175-5190. PubMed ID: 29844571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liposome encapsulation of curcumin and resveratrol in combination reduces prostate cancer incidence in PTEN knockout mice.
    Narayanan NK; Nargi D; Randolph C; Narayanan BA
    Int J Cancer; 2009 Jul; 125(1):1-8. PubMed ID: 19326431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chromatin-Associated Protein SIN3B Prevents Prostate Cancer Progression by Inducing Senescence.
    Bainor AJ; Deng FM; Wang Y; Lee P; Cantor DJ; Logan SK; David G
    Cancer Res; 2017 Oct; 77(19):5339-5348. PubMed ID: 28807943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor heterogeneity, aggressiveness, and immune cell composition in a novel syngeneic PSA-targeted Pten knockout mouse prostate cancer (MuCaP) model.
    van Duijn PW; Marques RB; Ziel-van der Made ACJ; van Zoggel HJAA; Aghai A; Berrevoets C; Debets R; Jenster G; Trapman J; van Weerden WM
    Prostate; 2018 Sep; 78(13):1013-1023. PubMed ID: 30133757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Jagged1 upregulation in prostate epithelial cells promotes formation of reactive stroma in the Pten null mouse model for prostate cancer.
    Su Q; Zhang B; Zhang L; Dang T; Rowley D; Ittmann M; Xin L
    Oncogene; 2017 Feb; 36(5):618-627. PubMed ID: 27345403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Murine cell lines derived from Pten null prostate cancer show the critical role of PTEN in hormone refractory prostate cancer development.
    Jiao J; Wang S; Qiao R; Vivanco I; Watson PA; Sawyers CL; Wu H
    Cancer Res; 2007 Jul; 67(13):6083-91. PubMed ID: 17616663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mouse models of prostate adenocarcinoma with the capacity to monitor spontaneous carcinogenesis by bioluminescence or fluorescence.
    Liao CP; Zhong C; Saribekyan G; Bading J; Park R; Conti PS; Moats R; Berns A; Shi W; Zhou Z; Nikitin AY; Roy-Burman P
    Cancer Res; 2007 Aug; 67(15):7525-33. PubMed ID: 17671224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.